Neurologist coverage within the competitive MS market
Read moreMultiple Sclerosis (MS) is one of the most competitive specialty markets we track, as a number of sophisticated players (i.e., Biogen, Teva, Sanofi, Serono, and Bayer) compete for a relatively small U.S. patient population. In the figure below we’ve charted...
Average frequency of paid interactions across specialty areas
Read moreWe’ve calculated the average number interactions per physician across several specialty areas by leveraging the 15M+ paid interactions tracked by the MDDetails platform. Note that the chart below suggests that the average rhuematologist is engaged more than twice as often as...
Case Study: Assessing rep access within high decile physicians
Read moreNearly every pharmaceutical sales and marketing organization shares the following belief: past script volume is a very good predictor of future script volume. This entrenched presumption has lead to the widespread use of historical prescribing behavior to segment physicians into prioritized groups...
Case Study: Characterizing experts, expertise, and relationships within PAH
Read morePulmonary arterial hypertension (PAH) is a serious condition caused by a rise in blood pressure due to thickening and loss of elasticity within pulmonary arteries. Patients with advanced stage disease require specialized care and are typically managed by cardiologists or...
Case Study: Prescriber access by specialty and geography
Read moreRecent publications, most notably the 2015 AccessMonitor survey, suggest that prescriber access has steadily fallen since 2008 and currently sits under 50% (See figure below, Source: ZS Associates). Our own analysis using the MDDetails platform (data on ~682,000 physicians) suggests that the 47% survey result reported by ZS is...